MedPath
HSA Approval

STREPSILS MAX PLUS LOZENGES

SIN08806P

STREPSILS MAX PLUS LOZENGES

STREPSILS MAX PLUS LOZENGES

July 11, 1996

RECKITT BENCKISER (SINGAPORE) PTE LTD

RECKITT BENCKISER (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRECKITT BENCKISER (SINGAPORE) PTE LTD
Licence HolderRECKITT BENCKISER (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

LOZENGE

ORAL

Medical Information

R02AA03

dichlorobenzyl alcohol

Manufacturer Information

RECKITT BENCKISER (SINGAPORE) PTE LTD

RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED

RECKITT BENCKISER HEALTHCARE MANUFACTURING (THAILAND) LTD

Active Ingredients

AMYLMETACRESOL

0.6 mg

Amylmetacresol

DICHLOROPHENYLCARBINOL

1.2 mg

dichlorophenylcarbinol

LIGNOCAINE HCl

10 mg

Lidocaine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

STREPSILS MAX PLUS LOZENGES - HSA Approval | MedPath